What is ParaGen Technologies?
Founded in 2016 and based in Dublin, Ohio, ParaGen Technologies operates at the intersection of material science and clinical biology. The company is dedicated to overcoming the historical limitations of synthetic and biologic implants by developing innovative synthetic nanofiber scaffolds. These structures are engineered to mimic the natural physical architecture of human tissue, thereby promoting superior healing outcomes and reducing the complications often associated with traditional implant materials. By bridging the gap between synthetic durability and biological compatibility, ParaGen is carving out a distinct niche in the competitive medical technology landscape.
How much funding has ParaGen Technologies raised?
ParaGen Technologies has raised a total of $4.1M across 1 funding round:
Share Placement
$4.1M
Share Placement (2020): $4.1M with participation from Undisclosed
Key Investors in ParaGen Technologies
Undisclosed Investors
What's next for ParaGen Technologies?
The infusion of capital from this major strategic investment will likely be directed toward scaling manufacturing capabilities and advancing clinical validation processes. As ParaGen Technologies transitions from its foundational development phase into a more mature enterprise-level operation, the focus will shift toward regulatory milestones and commercialization strategies. The company is expected to leverage these resources to expand its intellectual property portfolio and potentially initiate pilot studies that demonstrate the efficacy of its nanofiber technology in real-world clinical settings. This strategic growth phase is critical for establishing ParaGen as a leader in the next generation of regenerative medical devices.
See full ParaGen Technologies company page
